FREQUENCY OF RENAL DYSFUNCTION IN PATIENTS ADMITTED WITH ACUTE DECOMPENSATED HEART FAILURE AT A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.71000/e1b32080Keywords:
Acute Heart Failure, Blood Urea Nitrogen, Cardiorenal Syndrome, Comorbidity, , Creatinine, Glomerular Filtration Rate, Renal DysfunctionAbstract
Background: Acute decompensated heart failure (ADHF) is a critical clinical condition frequently complicated by renal dysfunction, which significantly worsens patient outcomes. The cardiorenal interaction poses diagnostic and therapeutic challenges, particularly in low-resource settings. Globally, renal dysfunction is recognized as an independent predictor of mortality in heart failure patients. In Pakistan, where comorbidities like diabetes and hypertension are highly prevalent, local data on renal impairment in ADHF remains limited, necessitating focused research to guide early risk identification and integrated management strategies.
Objective: To determine the frequency of renal dysfunction in patients admitted with acute decompensated heart failure at a tertiary care hospital.
Methods: A descriptive cross-sectional study was conducted over six months in the Adult Cardiology Department of the National Institute of Cardiovascular Diseases, Karachi. A total of 140 patients aged 18–75 years, with a primary diagnosis of ADHF, were enrolled using consecutive non-probability sampling. Serum creatinine, blood urea nitrogen (BUN), and estimated glomerular filtration rate (eGFR) were measured using standard protocols. Renal dysfunction was defined as eGFR < 60 mL/min/1.73 m² using the CKD-EPI equation. Data were analyzed using SPSS version 26, applying descriptive statistics, stratification, and inferential tests with p<0.05 considered significant.
Results: The mean age was 61.0 ± 9.0 years and mean BMI was 27.2 ± 3.5 kg/m². Males constituted 62.9% and 72.1% of patients were from urban areas. Hypertension was present in 75.7%, diabetes mellitus in 58.6%, and ischemic heart disease in 50.0% of cases. NYHA class III and IV were observed in 50.7% and 25.0%, respectively. The mean serum creatinine was 1.9 ± 0.6 mg/dL, BUN 26.4 ± 7.3 mg/dL, and eGFR 48.7 ± 19.6 mL/min/1.73 m². Renal dysfunction was noted in 77.9% of patients.
Conclusion: Renal dysfunction was highly prevalent in patients admitted with ADHF and strongly associated with advanced functional class and comorbid conditions. These findings support routine renal assessment to guide comprehensive management in heart failure care.
References
Chahid S, Ivanes F, Fauchier L. Is heart failure associated with a worse prognosis than cancer? Five-year survival following hospitalization with heart failure. Arch Cardiovasc Dis. 2024;117(1):S150. doi: 10.1016/j.acvd.2023.10.277
Bekmurodovna TK, Erkinovna EN, Gadaevich GA, Oripovna DN, Abduzhalolovna KF. Comorbid States in Patients with Chronic Heart Failure. Regional Level of the Problem (Preliminary Study). J Cardiovasc Dis Res. 2020;11(2):59- 65.
Natov PS, Ivey-Miranda JB, Cox ZL, Moreno-Villagomez J, Maulion C, Bellumkonda L, et al. Improvement in Renal Function During the Treatment of Acute Decompensated Heart Failure: Relationship With Markers of Renal Tubular Injury and Prognostic Importance. Circ Heart Fail. 2023 Mar;16(3):e009776. doi: 10.1161/CIRCHEARTFAILURE.122.009776
Savarese G, Vasko P, Jonsson Å, Edner M, Dahlström U, Lund LH. The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure. Ups J Med Sci. 2019 Jan;124(1):65-69. doi: 10.1080/03009734.2018.1490831
Lee HW, Huang CC, Yang CY, Leu HB, Huang PH, Wu TC, et al. Renal function during hospitalization and outcome in Chinese patients with acute decompensated heart failure: A retrospective study and literature review. Clin Cardiol. 2023 Jan;46(1):57-66. doi: 10.1002/clc.23934
Cooper L, DeVore A, Cowger J, Pinney S, Baran D, DeWald TA, et al. Patients hospitalized with acute heart failure, worsening renal function, and persistent congestion are at high risk for adverse outcomes despite current medical therapy. Clin Cardiol. 2023 Oct;46(10):1163-72. doi: 10.1002/clc.24080
Nafees Khan, Abdurhman Ali Mohammed Al-Hotam, Mohammed Abdulrahman Abdulfattah Ahmed, Sher Alam Khan, Bushra Khawaja, & Muhammad Hayat. (2024). IRON DEFICIENCY ANEMIA IN PEDIATRIC PATIENTS WITH FEBRILE SEIZURES: A CROSS-SECTIONAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology, 31(11), 1796-1802. https://doi.org/10.53555/3w7r2954
Khan MS, Shahid I, Anker SD, Fonarow GC, Fudim M, Hall ME, et al. Albuminuria and Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023;81(3):270-82.
Mc Causland FR, Lefkowitz MP, Claggett B, Anavekar NS, Senni M, Gori M, et al. Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction. Circulation. 2020;142(13):1236-45.
Lam CSP, Køber L, Kuwahara K, Lund LH, Mark PB, Mellbin LG, et al. Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial. Eur J Heart Fail. 2024;26(8):1727-35.
Han X, Zhang S, Chen Z, Adhikari BK, Zhang Y, Zhang J, et al. Cardiac biomarkers of heart failure in chronic kidney disease. Clin Chim Acta. 2020;510:298-310.
McCallum W, Sarnak MJ. Cardiorenal Syndrome in the Hospital. Clin J Am Soc Nephrol. 2023;18(7):933-45.
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-24.
Husain-Syed F, Gröne HJ, Assmus B, Bauer P, Gall H, Seeger W, et al. Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives. ESC Heart Fail. 2021;8(1):183-203.
Farrington DK, Surapaneni A, Matsushita K, Seegmiller JC, Coresh J, Grams ME. Discrepancies between Cystatin C-Based and Creatinine-Based eGFR. Clin J Am Soc Nephrol. 2023;18(9):1143-52.
Chatur S, Neuen BL, Claggett BL, Beldhuis IE, Mc Causland FR, Desai AS, et al. Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure. J Am Coll Cardiol. 2024;83(22):2148-59.
Kang H, Zhang J, Zhang X, Qin G, Wang K, Deng Z, et al. Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: A meta-analysis. Eur J Pharmacol. 2020;884:173444.
Berg DD, Samsky MD, Velazquez EJ, Duffy CI, Gurmu Y, Braunwald E, et al. Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial. Circ Heart Fail. 2021;14(2):e007034.
Packer M, Butler J, Zannad F, Pocock SJ, Filippatos G, Ferreira JP, et al. Empagliflozin and Major Renal Outcomes in Heart Failure. N Engl J Med. 2021;385(16):1531-3.
Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696-707.
Filippatos G, Anker SD, Pitt B, Rossing P, Joseph A, Kolkhof P, et al. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes. JACC Heart Fail. 2022;10(11):860-70.
Mc Causland FR, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, et al. Finerenone and Kidney Outcomes in Patients With Heart Failure: The FINEARTS-HF Trial. J Am Coll Cardiol. 2025;85(2):159-68.
Frampton JE. Finerenone: First Approval. Drugs. 2021;81(15):1787-94.
Dubin RF, Deo R, Ren Y, Wang J, Pico AR, Mychaleckyj JC, et al. Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification. Eur Heart J. 2024;45(30):2752-67.
Patel RB, Fonarow GC, Greene SJ, Zhang S, Alhanti B, DeVore AD, et al. Kidney Function and Outcomes in Patients Hospitalized With Heart Failure. J Am Coll Cardiol. 2021;78(4):330-43.
Hou YC, Zheng CM, Yen TH, Lu KC. Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection. Int J Mol Sci. 2020;21(21).
Yen FS, Hwu CM, Liu JS, Wu YL, Chong K, Hsu CC. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease. Ann Intern Med. 2024;177(6):693-700.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Aroona Kataria, Rakesh Kumar, FNU Neelam, Kainat Nasim, Farhan Khan, Rabia Adab, Deepak Kumar, Nasir Yaqoob (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.